front 1 Hospital and Health Care Facilities A health care facility is an organization that provides a physical environment for patients to obtain health care services such as a hospital, LTCF, a mental health facility, drug abuse treatment center, a penal institution or hospice. T/F All hospitals and health care facility pharmacies providing services involving the practice of pharmacy must register with the North Carolina Board of Pharmacy to receive a pharmacy permit. | back 1 TRUE NOTE: Healthcare facilities that ONLY administer drugs are exempt from registering with the North Carolina Board of Pharmacy similar to an outpatient surgical center. |
front 2 When are healthcare facilities EXEMPT from registering with the NC BOP and acquiring a pharmacy permit? | back 2 Healthcare Facilities that ONLY administer drugs |
front 3 What are THREE instances when separate pharmacy registrations/permits for dispensing drugs from physician's offices owned by the healthcare facilities are required? | back 3
|
front 4 The dispensing of drugs from physician's offices owned by the health care facility shall require a separate registration if: I. The drugs dispensed at the location are ordinarily and customarily obtained from a source outside of the healthcare facility. II. The Pharmacist manager is controlled and supervised from a source other than the health care facility pharmacy. III. The routine activity at the location is dispensing drugs to outpatients. A. I only B. I and II only C. II and III only D. All | back 4 D. All |
front 5 T/F Any pharmacy that provides compounding or dispensing services to one or more health care facilities for individual patient administration bearing any labeled name other than that under which it is registered shall require a separate registration. | back 5 TRUE |
front 6 If a hospital or healthcare facility is handling controlled substances, who must they be registered with? | back 6 NC Drug Control Unit NOTE: Community or retail pharmacies do not have to register with the NC Drug Control unit. |
front 7 A hospital or healthcare facility who is handling controlled substances must be registered with the NC Drug Control Unit. How often must they renew their registration with the NC Drug Control Unit? | back 7 Annually |
front 8 T/F | back 8 TRUE |
front 9 When discrepancies occur with controlled substance counts in a hospital or healthcare facility, Pharmacist Managers must report to which of following? I. NC Board of Pharmacy II. DEA III. FDA A. I only B. I and II only C. II and III only D. I, II and III | back 9 B. I and II only |
front 10 How soon shall discrepancies with controlled substance counts in a hospital or healthcare facility be reported to the Pharmacy Manager? | back 10 Within 24 hours |
front 11 In a hospital or healthcare facility medications are dispensed only upon receipt of a medication order. Medication Orders in a Hospital or Heathcare Facility can be in written, oral, fax or electronic form. NINE Elements of a Medication Order. | back 11
NOTE: There are no restrictions on the form of medication orders. Medication orders are not prescriptions. |
front 12 In a hospital or healthcare facility medications are dispensed only upon receipt of a medication order. Medication Orders in a Hospital or Heathcare Facility can be in written, oral, fax or electronic form. What do Medication Orders in a patient's profile contain? | back 12
|
front 13 T/F In a hospital or healthcare facility medications orders can be given in oral form. Oral medication orders shall be recorded immediately and signed by the physician. | back 13 TRUE |
front 14 In a hospital or healthcare facility which of the following are measures that can be taken to avoid indefinite open-ended medication orders? I. Routine monitoring of patient's drug therapy by pharmacist II. Automatic Stop Order Policy covering those medication orders that do not specify a number of doses or duration of therapy III. Automatic Cancellation of all medication orders after a predetermined time interval. A. I only B. I and II only C. II and III only D. I, II and III | back 14 D. I, II and III |
front 15 How often must healthcare facilities who credential practitioners for prescribing privileges provide the pharmacy with credentialling information for each practitioner? | back 15 Annually OR immediately if privileges are revoked NOTE: This lets the pharmacy know what practitioners are approved by the healthcare facility to write medication orders and see patients at that facility. |
front 16 In a hospital or healthcare facility all drugs dispensed must be labeled and identified to the point of administration. Labeling Requirements for Medications in a Hospital or Healthcare Facility: | back 16
|
front 17 In a hospital or healthcare facility all drugs dispensed must be labeled and identified to the point of administration. When a drug is added to a parenteral admixture, it shall be labeled with a distinctive supplementary label. What are the Supplementary Labeling Requirements for Parenteral Admixtures? | back 17
|
front 18 In a hospital or healthcare facility all drugs dispensed must be labeled and identified to the point of administration. Additional Labeling Requirements for Compounds: | back 18
|
front 19 Auxiliary Medication Inventories contain drugs and devices only in amounts to meet immediate therapeutic needs of patients. THREE Examples of Auxiliary Medication Inventories. | back 19
NOTE: Pharmacist manager and health care facility staff shall develop a list of drugs and devices. An auxiliary medication inventory shall ONLY contain drugs and devices only in amounts to meet immediate therapeutic needs of patients. |
front 20 The pharmacist manager in consultation with the medical staff must develop a list of drugs and devices that may be stocked in Auxiliary Medication Inventories. These drugs shall be labeled. FIVE Labeling requirements for drugs contained in Auxiliary Medication Inventories | back 20
|
front 21 When medications are taken out of the Auxiliary Medication Inventory. SEVEN items that must be recorded after withdrawal. | back 21
|
front 22 Which of the following is designed to meet the immediate therapeutic needs of patients? I. Emergency Kits II. Patient Care Unit Medication Inventories III. Ancillary Drug Cabinets Inventories A. I only B. I and II only C. II and III only D. I, II and III | back 22 D. I, II and III NOTE: Auxiliary Medication Inventories |
front 23 T/F | back 23 TRUE NOTE: The ONLY exception is when being used as an emergency kit. |
front 24 T/F In a healthcare facility setting, controlled substances may be stocked and removed from auxiliary medication inventories. | back 24 TRUE NOTE: Hospital or healthcare facility must make sure there is a record of these controlled substances. |
front 25 Which of the following is/are TRUE regarding auxiliary medication inventories? I. Only drugs in unit dose packaging shall be removed from the auxiliary medication inventory or from the pharmacy and administered to a specific patient in amounts to meet the needs for immediate therapeutic requirements. II. Controlled substances may be stocked and removed from auxiliary medication inventories. III. Drugs in auxiliary medication inventories shall be pre-labeled by the pharmacist with the drug name, strength, lot # and expiration date. A. I only B. I and II only C. II and III only D. All | back 25 D. All |
front 26 Which of the following describes a mechanical system that performs functions relating to the storage, packaging, counting, labeling and dispensing of medications and collects, controls, and maintains all transaction information? | back 26 Automated Dispensing or Drug Supply Device i.e., Pyxis machine NOTE: Can also be used as an auxiliary medication inventory or emergency kit. |
front 27 MEDICATION ORDERS need to be prospectively verified by the pharmacist before the nurse removes the drug from an Automated Dispensing Device (pyxis machine). What are THREE exceptions to this rule? | back 27
NOTE: With Auxiliary Medication Inventories, medication orders do not have to be prospectively reviewed prior to removal. |
front 28 T/F Automated Dispensing Devices may only be stocked by a pharmacist. | back 28 FALSE Automated Dispensing Devices can be stocked by non-pharmacist personnel. The pharmacist is still required to supervise the non-pharmacist personnel. |
front 29 Automated Dispensing Devices can be stocked by non-pharmacist personnel. Name THREE procedures that can be used for verification of stocking an Automated Dispensing Device. | back 29
|
front 30 THREE Qualifications of Validating Technicians. | back 30
|
front 31 Which of the following activities may a Validating Technician perform? I. Stock of patient care unit medications II. Stocking of ancillary drug cabinet inventories. III. Stocking of automated dispensing or drug supply devices. A. I only B. I and II only C. II and III only D. I, II and III | back 31 D. I, II and III |
front 32 Which of the following activities may a Validating Technician perform? I. Stock of emergency kits II. Validate the filling of floor stock and unit dose distribution systems. III. Prepackaging of prescription drugs within the hospital pharmacy. A. I only B. I and II only C. II and III only D. I, II and III | back 32 D. I, II and III |
front 33 Which of the following activities may a Validating Technician perform? A. Prepackage medications B. Stock Automated Dispensing Systems C. Verify a patient-specific medication order D. A & B E. All of the above | back 33 D. A & B NOTE: Verifying a patient-specific drug order can only be done by a pharmacist. |
front 34 How long shall transaction records (non-controlled and controlled medications) distributed by an Automated Dispensing Devices be kept? | back 34 3 years |
front 35 T/F Medication reuse from an Automated Dispensing Device is permissible. | back 35 TRUE NOTE: As long as the drug's purity, packaging and labeling have been examined, and it has been approved. |
front 36 T/F Automated Dispensing Devices must be used in a facility with a pharmacy permit. | back 36 TRUE NOTE: If NOT, it can ONLY be used as an emergency kit. |
front 37 In Summary Describe an Auxiliary Medication Inventory. | back 37
|
front 38 In Summary Describe an Automated Dispensing Device. | back 38
|
front 39 The emergency department staff is complaining about the long time it takes the pharmacy to deliver certain medications during a code situation. Which of the following ways could the pharmacy improve their turn around time? A. Install an Auxiliary Medication Inventory such as a drug cabinet B. Install an Automated Dispensing Device such as a Pyxis machine C. Both of the above D. Neither of the above | back 39 C. Both of the above NOTE: Auxiliary Medication Inventory is used to meet immediate therapeutic needs, however an Automated Dispensing Device can also be used as an Auxiliary Medication Inventory. |
front 40 Which of the following would be appropriate for a hospital pharmacy to install in order to quickly dispense patients' maintenance medications (i.e Metformin)? A. Auxiliary Medication Inventory such as a drug cabinet B. Automated Dispensing Device such as a Pyxis machine C. Both of the above D. Neither of the above | back 40 B. Automated Dispensing Device such as a Pyxis machine NOTE: This is not for the immediate therapeutic need of a patient; therefore, Auxiliary Medication Inventory would not be appropriate. |
front 41 Repackaging in a Hospital or Healthcare Facility Pharmacy T/F | back 41 FALSE Hospital or healthcare facilities DO NOT NEED TO register as a "Repackager" to repackage medications. |
front 42 Labeling Requirements for Repackaged Medications. | back 42
NOTE: Repackaging should be performed by or under the supervision of a pharmacist. |
front 43 Absence of a Pharmacist at a Hospital or Healthcare Facility In a healthcare facility a pharmacy is not open 24 hours a day, 7 days a week, arrangements need to be made for the provision of drugs and pharmaceutical care. What are the TWO options that the pharmacist-manager has to assure access to drugs in the absence of a pharmacist? | back 43
|
front 44 In absence of a pharmacist in a hospital or health care facility a nurse may be authorized to remove drugs from the pharmacy if... SATA A. Drug needed is not in auxiliary medication inventory. B. "On call" pharmacist is accessible C. Pharmacist maintains a list of authorized persons and documents the initial orientation, continuing education and quality control process. D. Pharmacist maintains a list of restricted medications that may not be removed from the pharmacy. | back 44 A. Drug needed is not in auxiliary medication inventory. B. "On call" pharmacist is accessible C. Pharmacist maintains a list of authorized persons and documents the initial orientation, continuing education and quality control process. D. Pharmacist maintains a list of restricted medications that may not be removed from the pharmacy. |
front 45 Which of the following are requirements for a nurse to remove medications from the pharmacy during the times a hospital pharmacy is not open? SATA A. Nurse must contact "on call" pharmacist for all medications removed B. Nurse must receive adequate training for removing medications from the pharmacy. C. All medications can be removed by a nurse from the pharmacy. D. Medication must be pre-labeled by a pharmacist. | back 45 A. Nurse must contact "on call" pharmacist for all medications removed B. Nurse must receive adequate training for removing medications from the pharmacy. D. Medication must be pre-labeled by a pharmacist. NOTE: Drugs must be pre-labeled by the pharmacist with the drug name, strength, lot # and expiration date. |
front 46 If a nurse removes a medication from a hospital pharmacy which is NOT OPEN 24 hours a day, during the absence of a pharmacist, within how many hours must a pharmacist obtain and verify a medication order? A. 24 hours B. 48 hours C. 72 hours D. 96 hours | back 46 A. 24 hours |
front 47 In the absence of a pharmacist, how long must the record of inventory removed from the pharmacy be kept? | back 47 3 years |
front 48 How often shall the pharmacist-manager verify the accuracy of the records of medications removed from the pharmacy in the absence of a pharmacist? | back 48 Quarterly |
front 49 T/F Supportive personnel may work in the pharmacy during the absence of a pharmacist to perform clerical, repackaging and distributive functions. | back 49 TRUE NOTE: Drugs may leave the pharmacy ONLY if checked by a pharmacist. |
front 50 T/F | back 50 FALSE Controlled substances MAY be stocked and removed from auxiliary medication inventories. Controlled substances CANNOT be removed from the pharmacy in the absence of a pharmacist. |
front 51 In a hospital or healthcare facility pharmacy the responsible pharmacists and pharmacy technicians for medication compounding and dispensing must be recorded and identified. How long must these records be kept? | back 51 30 days |
front 52 In a hospital or healthcare facility a Pharmacist-Manager shall document medication errors resulting from the administration of an incorrect medication or dose. How long shall these records be kept | back 52 3 years |
front 53 In a hospital or healthcare facility a Pharmacist-Manager shall retain all documents, labels, vials, supplies, substances, and internal investigation reports relating to an event where a prescription drug has caused or contributed to death of a patient. How long shall these records be kept? | back 53 3 years NOTE: When a patient dies as a result of a medication error it must be reported to the NC Board of Pharmacy within 14 days |
front 54 In a hospital or healthcare facility a Pharmacist-Manager shall maintain records of ordering, receiving, dispensing, or transfer of controlled substances. How long shall these records be kept? | back 54 3 years |
front 55 T/F | back 55 TRUE |
front 56 How soon must records from a hospital or healthcare facility be available to the NC Board of Pharmacy? | back 56 Within 48 hours |
front 57 T/F All hospital records must be kept for 3 years. | back 57 FALSE Day to day records that identify the responsible pharmacist and pharmacy technician for medication compounding and dispensing must be kept for 30 days. |
front 58 Health Care Facility Emergency Departments are permissible to dispense medications to patients of emergency departments and for patients to take home. Labeling Requirements for Medications Dispensed from ED | back 58
|
front 59 Which of the following are TRUE regarding medications being dispensed from a healthcare facility emergency department? I. A prescription needs to be issued from a practitioner. II. Patient is required to be counseled. III. If a 24-hour outpatient pharmacy is not available a prescription may be dispensed and is limited to not more than a 48-hour supply or the smallest commercially available quantity. A. I only B. I and II only C. II and III only D. I, II and III | back 59 B. I and II only NOTE: If a 24-hour outpatient pharmacy is not available a prescription may be dispensed and is limited to not more than a 24-hour supply or the smallest commercially available quantity. |
front 60 An emergency department of health care facilities having 24-hour outpatient pharmacy service shall consist of drugs that meet the immediate needs of emergency department patients. Quantities in each container shall be limited to not more than: A. 24-hour supply B. 48-hour supply C. 72-hour supply D. a weekly supply | back 60 A. 24-hour supply |
front 61 How long should a Perpetual Record of all dispensed drugs be maintained with pharmacy records? | back 61 3 years |
front 62 In a Hospital and Healthcare Facility Pharmacy the Perpetual Record should contain. | back 62
|
front 63 How often shall a Pharmacist-Manager of a hospital or healthcare facility pharmacy verify the accuracy of a Perpetual Record? | back 63 Monthly |
front 64 Medication orders in health care facilities, without a quantity indicated on the order, should be limited to which of the following day supply? A. 7 days B. 15 days C. 30 days D. 60 days | back 64 C. 30 days |
front 65 Long Term Care Facilities (LTCF) These facilities are a hybrid between hospitals and nursing homes who may be serviced by pharmacy. T/F | back 65 TRUE |
front 66 Long Term Care Facilities (LTCF) T/F An automated dispensing device can be installed in a LTCF by a retail pharmacy registered with the DEA. LTCFs are allowed to have controlled substances in an automated dispensing device. | back 66 TRUE NOTE: ONLY if registered with the DEA. If not registered with the DEA LTCFs may not order or maintain stocks of controlled substances. |
front 67 T/F The retail pharmacy that installs the Automated Dispensing Device must maintain a separate DEA registration at the LTCF location. | back 67 TRUE NOTE: Retail Pharmacy may keep records of the Automated Dispensing Device at their pharmacy. |
front 68 T/F | back 68 TRUE NOTE: Can apply for a Limited-Service Permit. |
front 69 T/F A pharmacy can place an emergency kit with controlled substances in a non-DEA registered LTCF. | back 69 TRUE NOTE: The pharmacy is responsible for the emergency kit and must be registered with the DEA. Therefore, it is considered an extension of the pharmacy and is covered under the pharmacy's DEA registration. A separate DEA registration is not needed. unlike when a pharmacy placed an Automated Dispensing Device in a LTCF that contains controlled substances. |
front 70 How many controlled substances can be contained in an Emergency Kit within a LTCF? | back 70 7 Controlled Drug Entities (C-II through C-V)
|
front 71 What must be established for a LTCF nurse or employee to be an agent of the patient's prescriber? | back 71 Written agreement |
front 72 LTCF Agents of a Prescriber (LTCF nurse or employee) may perform which of the following tasks? I. Call in an emergency oral C-II prescription to the pharmacy II. Transmit a fax prescription for all controlled and non-controlled substances from the prescriber. III. Prepare a written prescription for the signature of the practitioner. A. I only B. I and II only C. II and III only D. I, II and III | back 72 C. II and III only NOTE: Agents of a prescriber at a LTCF can ONLY call in a prescription for non-controlled substances and CIII, CIV and CV to the pharmacy. |
front 73 Nuclear Pharmacy (Not Completed) How many hours of TRAINING must a NUCLEAR Pharmacist receive? | back 73
|
front 74 Label Affixed to the Immediate INNER Container of Radiopharmaceutical, | back 74
|
front 75 Label Affixed to the Immediate OUTER Container of Radiopharmaceutical, | back 75
|
front 76 What protects individually identifiable health information held or transmitted by a covered entity or its business associate? | back 76 HIPAA |
front 77 HIPAA is also known as | back 77 Protected Health Information (PHI) |
front 78 HIPAA... I. Relates to the individuals past, present or future physical or mental health or condition II. Identifies the individual name, address, phone number or vehicle information. III. Includes electronic, paper or oral form A. I only B. I and II only C. II and III only D. I, II and III | back 78 D. I, II and III |
front 79 A covered entity must comply with HIPAA and includes health care plans, health care providers such as prescribers, pharmacies and pharmacists, and personnel that conduct transactions electronically. What are TWO exemptions for when a covered entity may disclose Protected Health Information (PHI)? | back 79
NOTE: Personal representative is a person legally authorized to make health care decisions on individual's behalf such as a parent of a minor or a person who has power of attorney. |
front 80 What are THREE exemptions for when a pharmacy can disclose Protected Health Information (PHI)? | back 80
NOTE: "TPO" |
front 81 HIPAA does not require that every risk of an incidental use or disclosure of PHI be eliminated. What must pharmacies implement to prevent the disclosure of information? | back 81 Reasonable Safeguards NOTE: Designated areas for counseling, stand behind this line signs, using indoor voices. |
front 82 When protecting patient's health information, the use of only the minimum amount of information is necessary to accomplish the intended purpose of the use, disclosure or request. Pharmacies should use the "Minimum Necessary" when possible. What are FOUR exceptions to the "Minimum Necessary" requirement? | back 82
|
front 83 A customer walks by the pharmacy and accidently hears you counseling a patient about his medications. Which of the following best describes this situation? A. Breach of PHI B. Incidental Use and Disclosure C. Minimum Necessary Requirement D. Notice Provision | back 83 B. Incidental Use and Disclosure |
front 84 Each covered entity (including a pharmacy) must provide a notice of its privacy practices. Which of the following are TRUE regarding Privacy Practice Notice? I. Notice must contain several elements, concerning how the covered entity will use the patient's PHI, safeguards and grievance process. II. Notice must be posted in a clear and prominent place. III. Notice must be delivered to patients not later than the second service encounter. A. I only B. I and II only C. II and III only D. I, II and III only | back 84 B. I and II only NOTE: Notice must be delivered to patients not later than the FIRST service encounter. |
front 85 T/F A covered entity must supply Privacy Practice Notice to anyone on request and make electronically available on web site. | back 85 TRUE |
front 86 T/F Pharmacies must make a good faith effort to obtain a written, electronic or mail acknowledgement by all patients that they received the Privacy Practice Notice. | back 86 TRUE |
front 87 T/F If a patient refuses to sign the acknowledgement of Privacy Practice Notice Receipt, treatment can be refused. | back 87 FALSE If a patient refuses to sign the acknowledgement of Privacy Practice Notice Receipt, treatment CANNOT be refused. NOTE: Only can be signed by the patient or the patient's personnel representative (Parent of minor or Power of Attorney) Only required ONCE for each patient even if you update your Privacy Practice Notice. |
front 88 Which of the following is TRUE regarding acknowledgement of Privacy Practice Notice when received by the patient? I. Treatment can be refused if the patient refuses to sign the Privacy Practice Notice. II. The reason for failing to obtain the patient's written acknowledgement must be documented. III. Written acknowledgement is only required once for each patient. A. I only B. I and II only C. II and III only D. I, II, and III | back 88 C. II and III only If a patient refuses to sign the acknowledgement of Privacy Practice Notice Receipt, treatment CANNOT be refused. |
front 89 The acknowledgement of Privacy Practice Notice can only be signed by the patient or the patient's personnel representative (parent of minor or Power of Attorney). If a prescription is filled for a patient and their spouse picks up the prescription and the spouse does not have Power of Attorney. How will the Privacy Practice Notice be signed? | back 89 The Privacy Practice Notice may be sent to the patient by mail to be acknowledged and signed by the patient. |
front 90 A breach of PHI is defined as an impermissible use or disclosure under the privacy rule that compromises the security of the protected health information. TWO Exceptions of a Protected Health Information (PHI) Breach. | back 90
|
front 91 The pharmacy must determine if a breach occurred and document if the breach met an exclusion. How long must documentation of a potential breach be retained? | back 91 6 years |
front 92 On a federal level, following the discovery of a breach, who must be notified? I. Individuals Affected by the Breach II. The Secretary of DHHS III. The Secretary of DEA A. I only B. I and II only C. II and III only D. I, II, and III | back 92 B. I and II only |
front 93 On a federal level, how soon must covered entities notify affected individuals following the discovery of a breach? | back 93 Without unreasonable delay and no later than 60 days after discovery by mail or electronically |
front 94 On a federal level, how soon must covered entities notify the Secretary of DHHS following the discovery of a breach? | back 94 No later than 60 days after the end of the calendar year in which the breach was discovered |
front 95 On a federal level, if MORE THAN 500 individuals are affected by a breach, who must the pharmacy notify? I. The affected individuals II. The Secretary of DHHS III. The media A. I only B. I and II only C. II and III only D. I, II, and III | back 95 D. I, II, and III NOTE: |
front 96 On a federal level, if MORE THAN 500 individuals are affected by a breach, how soon must the pharmacy notify individuals affected, the secretary of DHHS, and the media? | back 96 Without unreasonable delay and no later than 60 days after discovery of breach |
front 97 In North Carolina a breach of personal health information requires notification without unreasonable delay to which of the following: I. Secretary of DHHS II. Individuals Affected by the Breach III. North Carolina Attorney General's Consumer Protection Division A. I only B. I and II only C. II and III only D. I, II, and III | back 97 C. II and III only |
front 98 In North Carolina, if a breach includes more than _________ individuals, all reporting agencies must be notified. | back 98 In North Carolina, if a breach includes more than 1,000 individuals, all reporting agencies must be notified. |
front 99 Marketing is communication by telephone mail and/or email about a product or service that encourages the recipient to purchase or use the product or service. What are FOUR exceptions to the definition of marketing? | back 99
|
front 100 Which of the following is considered marketing? I. Communication by telephone II. Communication by mail or email III. Communication face to face A. I only B. I and II only C. II and III only D. I, II and III | back 100 B. I and II only |
front 101 Which of the following is considered marketing? I. A covered entity selling personal health information (PHI) to another business for that business' own purposes. II. Describing health related products or services offered by the covered entity. III. Handing patients printed drug information. A. I only B. I and II only C. II and III only D. I, II and III | back 101 A. I only |
front 102 Your pharmacy is beginning a wellness program and would like to identify all patients with diabetes, high cholesterol, and heart disease to encourage enrollment. May you utilize your pharmacy records to identify patients and send them information on your program without obtaining consent? A. Yes B. No | back 102 A. Yes NOTE: This is an exception to marketing. |
front 103 A covered entity may sell personal health information to another business for that business' own purposes; however, a covered entity must obtain patient authorization for any use or disclosure of personal health information for marketing purposes. What must this authorization include? | back 103
|
front 104 A pharmaceutical company would like the names of all your diabetic patients so they can send them mail about their new diabetes drugs. May you provide the pharmaceutical company with this information without obtaining the patient's consent? A. Yes B. No | back 104 B. No NOTE: This is marketing which requires the patient's consent. |
front 105 T/F Covered entities must document that each employee has completed HIPAA training. | back 105 TRUE |
front 106 T/F Covered entities must develop policies and procedures and identify a privacy officer to oversee the entity's compliance with HIPAA. | back 106 TRUE |
front 107 Miscellaneous Federal Pharmacy Laws Adulterated OR Misbranded Contains in whole/part any filthy, putrid or decomposed substance | back 107 Adulterated |
front 108 Adulterated OR Misbranded Generic or established name is not on the label. | back 108 Misbranded |
front 109 Adulterated OR Misbranded Has been prepared, packaged or held under unsanitary conditions | back 109 Adulterated |
front 110 Adulterated OR Misbranded The labeling is false or misleading in any manner. | back 110 Misbranded |
front 111 Adulterated OR Misbranded Has been manufactured under conditions that do not meet GMP standards. | back 111 Adulterated |
front 112 Adulterated OR Misbranded Quantity of container contents are not present. | back 112 Misbranded NOTE: Word, statement or other information not prominently placed on label as required by law. |
front 113 Adulterated OR Misbranded Medications stored in room with extreme temperatures. | back 113 Adulterated |
front 114 Adulterated OR Misbranded Manufacture, packer or distributor name and place of business not on label. | back 114 Misbranded |
front 115 Adulterated OR Misbranded Manufacture is not registered with the FDA | back 115 Misbranded |
front 116 Adulterated OR Misbranded Dispensing a prescription without a prescription or refills. | back 116 Misbranded |
front 117 Adulterated OR Misbranded Strength, quality or purity differs from compendia standards (USP). | back 117 Adulterated |
front 118 Adulterated OR Misbranded Dispensing the incorrect strength of a prescription drug. | back 118 Misbranded |
front 119 Adulterated OR Misbranded Not following regulations of the Poision Prevention Packaging Act. | back 119 Misbranded |
front 120 Adulterated OR Misbranded Failure to manufacture OTC products in tamper evident packaging. | back 120 Misbranded or Adulterated |
front 121 A new OTC medication claims that it will reverse coronary atherosclerosis if taken. Upon further investigation of the FDA, the manufacturer does not have clinical data to prove this statement. Which of the following violations have occurred? A. Adulteration B. Misbranding | back 121 B. Misbranding |
front 122 A pharmacy dispenses nitroglycerin to a patient in a plastic vial. Nitroglycerin adheres to plastic causing a loss of potency. Which of the following violations have occurred? A. Adulteration B. Misbranding | back 122 A. Adulteration |
front 123 If a pharmacy dispenses Atorvastatin to a patient and the patient does not have any valid refills remaining, which of the following violations occurred? A. Adulteration B. Misbranding | back 123 B. Misbranding |
front 124 If a marketed drug product exhibits problems, the manufacture is encouraged to issue a drug recall notice. Class 1 Drug Recall (Most Severe) | back 124
|
front 125 If a marketed drug product exhibits problems, the manufacture is encouraged to issue a drug recall notice. Class 2 Drug Recall | back 125
|
front 126 If a marketed drug product exhibits problems, the manufacture is encouraged to issue a drug recall notice. Class 3 Drug Recall (Least Severe) | back 126
|
front 127 What insulin(s) are over the counter and do not require a prescription? | back 127
NOTE: Prescription ONLY insulins include Regular U-500, Humalog, Novolog, Lantus and Levemir |
front 128 Which Regular Insulin is prescription ONLY? | back 128 Regular Insulin U-500 |
front 129 All healthcare facilities are prohibited from discharging hazardous waste pharmaceuticals to a sewer system such as down a sink or flushing down a toilet. Hazardous waste includes any drug that is identified as ignitability, corrosivity, reactivity or toxicity. Which of the following classes of drugs are prohibited from being discharged into a sewer system? I. Prescription Drugs II. Compounded Drugs III. OTC and Dietary Supplements A. I only B. I and II only C. II and III only D. I, II and III | back 129 D. I, II and III |
front 130 What is a unit of drug not intended for sale and intended to promote the sale of the drug product? | back 130 Drug Sample |
front 131 T/F Pharmacies may receive drug samples, but are prohibited from dispensing drug samples. | back 131 FALSE Pharmacies are prohibited from receiving and dispensing drug samples. |
front 132 T/F Prescribers do not need a pharmacy permit if they are only dispensing drug samples. Prescribers must follow all packaging, labeling and record keeping requirement laws for prescription drugs when dispensing drug samples. | back 132 TRUE |
front 133 T/F | back 133 FALSE Manufactures can distribute a controlled substance drug sample to a PRESCRIBER only after the PRESCRIBER makes a written request. |
front 134 Manufactures can distribute a controlled substance drug sample to a PRESCRIBER only after the PRESCRIBER makes a written request. What is included in the written request for a controlled substance drug sample? | back 134
|
front 135 Manufactures can distribute a controlled substance drug sample to a PRESCRIBER only after the PRESCRIBER makes a written request. How long must the manufacture keep the written request? | back 135 3 years |
front 136 T/F | back 136 TRUE |
front 137 FDA requires a pharmacy to dispense a manufacturer-provided patient package insert (PPI) to the patient. TWO classes of medications that require a patient package insert (PPI)? | back 137
NOTE: Regulated by the FDA. |
front 138 In a community pharmacy when is the Patient Package Insert (PPI) given to the patient? In a hospital/institutional pharmacy when is a Patient Package Insert (PPI) given to the patient? | back 138 Community: Given with each package dispensed Institutional Hospital: Before administration of first oral contraception and 30 days thereafter |
front 139 T/F Drug leaflets are regulated by the FDA and are required to be provided to all patients when dispensing medications. | back 139 FALSE Drug leaflets are not regulated by the FDA and it is left up to individual pharmacies to provide for all medications dispensed. |
front 140 What is given and applies to certain drugs and biological products that the FDA determines to pose a serious and significant public health concern? | back 140 MedGuides |
front 141 Give FOUR examples of medications that require a MedGuide. | back 141
|
front 142 Manufactures provide the MedGuides to the pharmacy. MedGuides are required if: I. Could help prevent serious adverse effects II. There is a serious risk that a patient should be aware of. III. Patient adherence to directions is crucial. A. I only B. I and II only C. II and III only D. I, II and III | back 142 D. I, II and III |
front 143 What is required and ensures that the benefits of certain prescription drugs outweigh their risk? | back 143 Risk Evaluation and Mitigation Strategy (REMS) NOTE: Healthcare professionals and distributors may need to follow specific safety procedures prior to prescribing, shipping or dispensing the drug. |
front 144 FOUR Elements of the REMS Program | back 144
|
front 145 THREE Examples of REMS Medications. | back 145
|
front 146 Prescriptions must be designated to prevent unauthorized copying, erasure or modification and use of counterfeit prescriptions. T/F Written outpatient Medicaid prescriptions must be written on tamper-resistant prescription pads. | back 146 TRUE |
front 147 What are 340B Drugs? | back 147 Medications that are provided to a contract pharmacy at a reduced cost and are dispensed to underserved and uninsured populations. |
front 148 T/F Pharmacies may only dispense 340B drugs to patients in the 340B program. | back 148 TRUE |
front 149 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product with an "In-Use" Time | back 149 "In-Use" Time or Expiration Date (whichever is shorter) |
front 150 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product NONAQUEOUS formulation (tablet or capsule): | back 150 6 months OR Expiration Date (whichever is shorter) |
front 151 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product Water Containing Oral Formulation (Solution or Suspensions): | back 151 14 days OR Expiration Date (whichever is shorter) |
front 152 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Non-Sterile Drug Product Water Containing Topical/Dermal and Mucosal Liquid and Semisolid Formulations. | back 152 30 days OR Expiration Date (whichever is shorter) |
front 153 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Sterile Drug Products with an "In-Use" Time | back 153 "In-Use" Time OR Expiration Date (whichever is shorter) |
front 154 Repackaging drugs must be in accordance with USP 795 and USP 797 and are only dispensed after receiving a prescription or medication order. What is the Beyond-Use-Date (BUD) for repackaging a: Sterile Drug Products without In-Use Time | back 154 According to USP 797 OR Expiration Date (whichever is shorter) |
front 155 EIGHT Labeling Factors of Over-the-Counter Drug Products. | back 155
|
front 156 National Drug Code (NDC) Number How many digits are contained in an NDC Number? | back 156 11 Digits (3 Segements) |
front 157 There are 11 digits and 3 segments in an NDC number. What does each segment represent? | back 157
|
front 158 What is the Federal Anti-Tampering Act? | back 158 This act requires manufacturers to package OTC drugs in tamper-evident packaging. |
front 159 Medical Devices: Which class of medical devices requires "specific controls" to be met and includes blood pressure cuffs, syringes and percutaneous catheters? | back 159 Class II |
front 160 Medical Devices: Which class of medical devices requires manufactures to provide "general controls" during the production of the device and includes stethoscopes, bandages and crutches. | back 160 Class I |
front 161 Medical Devices: Which class of medical devices require premarket approval because the device is life-sustaining, important in preventing impairment of human health and includes pacemakers, replacement heart valves, coronary stents? | back 161 Class III |
front 162 TWO USPS Mailing Requirements for Controlled Substances. | back 162
|
front 163 USP 800 Describes practice and quality standards for the receipt, storage, compounding, dispensing, administration and disposal of sterile and nonsterile Hazardous Drugs (HDs). Hazardous drugs are identified by: | back 163 National Institute for Occupational Safety and Health (NIOSH) |
front 164 How often must entities review their list of hazardous drugs? | back 164 Every 12 months or when a new agent or dosage form is introduced |
front 165 Which of the following is legal in NC? A. Death with dignity/ physician-assisted suicide B. Medical marijuana (THC) for chronic pain C. Investigational drugs outside of clinical trials ("Right to Try") D. Prescribing controlled substances for family members | back 165 C. Investigational drugs outside of clinical trials ("Right to Try") |